Abiopharma

EHC Investors Have Opportunity to Join Encompass Health Corporation Fraud Investigation with the Schall Law Firm

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

RARE Investors Have Opportunity to Join Ultragenyx Pharmaceutical Inc. Fraud Investigation with the Schall Law Firm

Encompass Health Corporation - Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Cleveland, Tennessee

Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Cleveland, Tennessee

Hemostemix Closing $3,000,000 Private Placement and Issues TCDs

PMGC Holdings Inc. Completes Acquisition of CNC Machining Company - AGA Precision Systems LLC

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN